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Detoxification, the initial step in the 
treatment of opiate dependence (Freedman, 
1980) has been facing difficulties in our 
country as the widely used drug methadone 
is not available. Earlier practices were 
either abrupt withdrawal or gradual taper-
ing of the dose of the opiate to which the 
individual was dependent. Recently clo-
nidine has been used with success for detoxi-
fication and treatment of opiate withdrawal 
symptoms (Gold et al., 1978; Washton and 
Resnick,. 1980; Channabasavanna and 
Subramanya, 1981). Glonidine acts through 
inhibiting the norepinephrinergic system 
by a presynaptic feedback mechanism 
(Hamburg and Fallman, 1981). Studies 
comparing the efficacy of clonidine with 
other methods of opiate detoxification are 
rather few (Washton and Resnick, 1980). 
The present study was conducted to com-
pare the efficacy of a clonidine with the 
earlier methods of detoxification, namely 
abrupt withdrawal and gradual tapering. 
MATERIAL AND METHODS 
Patient sample comprised of nineteen 
male patients of age group 21-53 years, 
who met the DSM III criteria (American 
Psychiatric Association, 1980) for opiate 
dependence. All the nineteen patients 
were dependent on parental opiates (mor-
phine or pethidine). Ten patients received 
clonidine (100 mg) tablets from the day 
of admission. The mean interval between 
the last dose of the opiate and the initiation 
of clonidine treatment was 28 hours (SD= 
6.3). The dosage was rapidly stepped up 
to the needs of a given patient (from three 
tablets per day to a maximum of nine 
tablets per day, within two to three days). 
Blood pressure was recorded at eight hourly 
intervals in these patients. Glonidine was 
tapered off within two to three days after 
the patients were symptom free for one 
week. The severity of withdrawal symptoms 
at the time of admission was graded using 
a rating scale (Blanchly, 1966). For a 
control group, case charts of nine patients 
who were detoxified either by abrupt with-
drawal (n=4) or by gradual tapering of 
the opiate (n=5) were selected. The 
information available in all these nine 
charts was complete. Based on the records 
the severity of the withdrawal symptoms 
of these patients at the lime of admission 
was also graded similarly (Blanchly, 1966). 
Patients received tranquillizers and other 
symptomatic treatment as determined by 
clinical State. The total amount of opiates 
they were receiving per day prior to admis-
sion was similar in both the clonidine and 
control group. The severity of withdrawal 
symptoms at the time of admission were 
comparable in the two groups. Within 
the control group there were no statistically 
significant differences between the abrupt 
withdrawal group and the gradual tapering-
dose group with respect to the severity of 
withdrawal symptoms at admission, dura-
tion of hospital stay and the cost of drugs 
used per patient. All patients were dis-
charged drug free and symptomfree. The 
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efficacy of clonidine was judged by com-
paring the number of days of hospitaliza-
tion required for detoxification and the 
cost of all drugs given to the patients during 
their hospital stay in the two groups. 
RESULTS 
Clonidine controlled the non-purposive 
withdrawal symptoms within two or three 
days following abrupt opiate withdrawal. 
However purposive withdrawal symptoms 
persisted much longer, i.e., eight to ten 
days. None of the patients developed new 
withdrawal symptoms after being started 
on clonidine. This indicates that clonidine 
can also effectively prevent the further 
occurrance of withdrawal symptoms in 
those who have already manifested. None 
of the patients while receiving clonidine 
developed either hypotension, sedation or 
dryness of mouth as a side effect. Even 
though on statistical tests the difference 
50T 
1 
A 
1 1 
B 
Figure 1 : A. Mean ^ SEM number of days of 
hospitalization. 
B. Mean ± SEM. Cost of all drugs used 
during hospitalization (in rupees) 
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in the mean number of days of hospitaliza-
tion between the two groups did not reach 
statistical significance, it can be seen from 
Fig. 1 that patients treated with clonidine 
tended to get discharged early. The cost 
of providing treatment with clonidine when 
compared to the earlier methods was not 
significantly higher (Fig. 1). 
DISCUSSION 
Clonidine is a widely used antihyper-
tensive drug with no addictive potential 
(Lancet, 1980). The safety and efficacy 
of the drug facilitates detoxification of 
opiate addicts even at peripheral hospitals 
without much additional cost and may in 
fact be done in a shorter period. The 
findings are of particular importance to the 
physicians from countries where methadone 
is not available. We suggest that even where 
the methadone is available it is worth 
comparing clonidine with the former drug 
with respect to its cost effectiveness. 
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